Does RADIUM RA-223 DICHLORIDE Cause General physical health deterioration? 308 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 308 reports of General physical health deterioration have been filed in association with RADIUM RA-223 DICHLORIDE (Xofigo). This represents 6.4% of all adverse event reports for RADIUM RA-223 DICHLORIDE.
308
Reports of General physical health deterioration with RADIUM RA-223 DICHLORIDE
6.4%
of all RADIUM RA-223 DICHLORIDE reports
77
Deaths
105
Hospitalizations
How Dangerous Is General physical health deterioration From RADIUM RA-223 DICHLORIDE?
Of the 308 reports, 77 (25.0%) resulted in death, 105 (34.1%) required hospitalization, and 7 (2.3%) were considered life-threatening.
Is General physical health deterioration Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RADIUM RA-223 DICHLORIDE. However, 308 reports have been filed with the FAERS database.
What Other Side Effects Does RADIUM RA-223 DICHLORIDE Cause?
Prostatic specific antigen increased (449)
Hormone-refractory prostate cancer (441)
Death (376)
Anaemia (324)
Metastases to bone (315)
Fatigue (242)
Haemoglobin decreased (236)
Prostate cancer (234)
Nausea (221)
Pain (215)
What Other Drugs Cause General physical health deterioration?
METHOTREXATE (5,767)
ADALIMUMAB (5,718)
INFLIXIMAB (5,403)
RITUXIMAB (5,178)
ABATACEPT (4,832)
LEFLUNOMIDE (4,420)
PREDNISONE (4,402)
LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN (4,332)
TOCILIZUMAB (4,254)
ETANERCEPT (3,898)
Which RADIUM RA-223 DICHLORIDE Alternatives Have Lower General physical health deterioration Risk?
RADIUM RA-223 DICHLORIDE vs RALOXIFENE
RADIUM RA-223 DICHLORIDE vs RALTEGRAVIR
RADIUM RA-223 DICHLORIDE vs RALTITREXED
RADIUM RA-223 DICHLORIDE vs RAMELTEON
RADIUM RA-223 DICHLORIDE vs RAMIPRIL